YOKNEAM, ISRAEL–(EMWNews – July 28, 2008) – Syneron Medical Ltd. (NASDAQ: ELOS), an

innovator in the development, marketing and sales of elos™

combined-energy medical aesthetic devices, today announced that it will

release its financial results for the second quarter of 2008 before market

opening on Thursday, August 14, 2008. The earnings release will be

available on Syneron’s website at www.syneron.com.

Syneron management will host a conference call and a live webcast at 8:30am

(ET) on the same day. A question & answer session will follow management’s

discussion of events in the second quarter.

Investors and analysts may participate in the conference call on the

following dial-in numbers:

US (toll free): 877-591-4949

International: +1-719-325-4942

Investors and other interested parties can also access a live webcast of

the conference call through the Investor Overview page on Syneron’s website

at www.syneron.com. Please log in at least 10 minutes prior to the

conference call in order to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be

available within 24 hours on the Company’s website.

About Syneron

Syneron Medical Ltd. (NASDAQ: ELOS) manufactures and distributes medical

aesthetic devices that are powered by the proprietary, patented elos

combined-energy technology of Bi-Polar Radio Frequency and Light. The

Company’s innovative elos technology provides the foundation for highly

effective, safe and cost-effective systems that enable physicians to

provide advanced solutions for a broad range of medical-aesthetic

applications including hair removal, wrinkle reduction, rejuvenating the

skin’s appearance through the treatment of superficial benign vascular and

pigmented lesions, and the treatment of acne, leg veins and cellulite.

Founded in 2000, the corporate, R&D, and manufacturing headquarters for

Syneron Medical Ltd. is located in Israel. Syneron has offices and

distributors throughout the world, including North American Headquarters in

Canada, North American Logistics Support Center in Irvine, CA, European

Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which

provide sales, service and support. Additional information can be found at

www.syneron.com.

Syneron, the Syneron logo, and elos are trademarks of Syneron Medical Ltd.

and may be registered in certain jurisdictions. elos (Electro-Optical

Synergy) is a proprietary technology of Syneron Medical Ltd. All other

names are the property of their respective owners.